JACKSONVILLE, Fla., Nov. 21, 2024 /PRNewswire/ -- By combining resources and expertise, Brooks Rehabilitation, Nemours Children's Health, Jacksonville, Wolfson Children's…
Symposium gathered top fighters, neuroscientists, and media together in New York City on eve of UFC 309 UFC Performance Institute leader,…
Startup Leverages ISS National Lab to Test Viral Vector That Delivers Gene Therapy KENNEDY SPACE CENTER, Fla., Nov. 21, 2024…
NEW YORK, Nov. 21, 2024 /PRNewswire/ -- Cause of a Kind, an award-winning leader in software and web development, has partnered…
CARDIFF, UK / ACCESSWIRE / November 21, 2024 / Biodexa Pharmaceuticals PLC (NASDAQ:BDRX), an acquisition-focused clinical-stage biopharmaceutical company focused on…
Vancouver, British Columbia--(Newsfile Corp. - November 21, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H) ("PreveCeutical" or the…
DehydraTECH-liraglutide and a select DehydraTECH-CBD formulation were the top performing groups in the Study outperforming the Rybelsus® control group in…
Reductions also seen in comorbid anxiety and depression symptomsBURLINGTON, Mass. and JERUSALEM, Israel, Nov. 20, 2024 (GLOBE NEWSWIRE) -- BrainsWay…
CARSON CITY, Nev., Nov. 20, 2024 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI), (“BioVie” or the “Company”), a clinical-stage company…
Company is evaluating IMSB301 in a Phase 1 clinical trial in healthy volunteers and plans to move rapidly into Phase…